Advertisement
Review Article| Volume 26, ISSUE 3, P491-500, July 2010

Immunosupression and Infection After Major Surgery: A Nutritional Deficiency

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Critical Care Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Mannick J.A.
        • Rodrick M.L.
        • Lederer J.A.
        The immunologic response to injury.
        J Am Coll Surg. 2001; 193: 237-244
        • Beale R.J.
        • Bryg D.J.
        • Bihari D.J.
        Immunonutrition in the critically ill: a systematic review of clinical outcome.
        Crit Care Med. 1999; 27: 2799-2805
        • Daly J.M.
        • Lieberman M.D.
        • Goldfine J.
        • et al.
        Enteral nutrition with supplemental arginine, RNA, and omega-3 fatty acids in patients after operation: immunologic, metabolic, and clinical outcome.
        Surgery. 1992; 112: 56-67
        • Tepaske R.
        • Velthuis H.
        • Oudemans-van Straaten H.M.
        • et al.
        Effect of preoperative oral immune-enhancing nutritional supplement on patients at high risk of infection after cardiac surgery: a randomised placebo-controlled trial.
        Lancet. 2001; 358: 696-701
        • Heyland D.K.
        • Novak F.
        • Drover J.W.
        • et al.
        Should immunonutrition become routine in critically ill patients? A systematic review of the evidence.
        JAMA. 2001; 286: 944-953
        • Popovic P.J.
        • Zeh III, H.J.
        • Ochoa J.B.
        Arginine and immunity.
        J Nutr. 2007; 137: 1681S-1686S
        • Bronte V.
        • Serafini P.
        • Mazzoni A.
        • et al.
        L-arginine metabolism in myeloid cells controls T-lymphocyte functions.
        Trends Immunol. 2003; 24: 302-306
        • Morris Jr, S.M.
        Regulation of arginine availability and its impact on NO synthesis.
        in: Ignarro L.J. Nitric oxide: biology and pathobiology. Academic Press, San Diego (CA)2000: 187-197
        • Morris Jr., S.M.
        Arginine: beyond protein.
        Am J Clin Nutr. 2006; 83: 508S-512S
        • Seifter E.
        • Rettura G.
        • Barbul A.
        • et al.
        Arginine: an essential amino acid for injured rats.
        Surgery. 1978; 84: 224-230
        • Wakabayashi Y.
        • Yamada E.
        • Yoshida T.
        • et al.
        Arginine becomes an essential amino acid after massive resection of rat small intestine.
        J Biol Chem. 1994; 269: 32667-32671
        • Barbul A.
        • Wasserkrug H.L.
        • Seifter E.
        • et al.
        Immunostimulatory effects of arginine in normal and injured rats.
        J Surg Res. 1980; 29: 228-235
        • Ochoa J.B.
        • Udekwu A.O.
        • Billiar T.R.
        • et al.
        Nitrogen oxide levels in patients after trauma and during sepsis.
        Ann Surg. 1991; 214: 621-626
        • Tsuei B.J.
        • Bernard A.C.
        • Barksdale A.R.
        • et al.
        Supplemental enteral arginine is metabolized to ornithine in injured patients.
        J Surg Res. 2005; 123: 17-24
        • Jacob T.D.
        • Ochoa J.B.
        • Udekwu A.O.
        • et al.
        Nitric oxide production is inhibited in trauma patients.
        J Trauma. 1993; 35 ([discussion: 596–7]): 590-596
        • Lovett III, J.E.
        • Fink B.F.
        • Bernard A.
        • et al.
        Analysis of nitric oxide activity in prevention of reperfusion injury.
        Ann Plast Surg. 2001; 46: 269-273
        • Ochoa J.B.
        • Strange J.
        • Kearney P.
        • et al.
        Effects of L-arginine on the proliferation of T lymphocyte subpopulations.
        JPEN J Parenter Enteral Nutr. 2001; 25: 23-29
        • Ochoa J.B.
        • Makarenkova V.
        T lymphocytes.
        Crit Care Med. 2005; 33: S510-S513
        • Zea A.H.
        • Rodriguez P.C.
        • Culotta K.S.
        • et al.
        L-arginine modulates CD3zeta expression and T cell function in activated human T lymphocytes.
        Cell Immunol. 2004; 232: 21-31
        • Rodriguez P.C.
        • Zea A.H.
        • DeSalvo J.
        • et al.
        L-arginine consumption by macrophages modulates the expression of CD3 zeta chain in T lymphocytes.
        J Immunol. 2003; 171: 1232-1239
        • Taheri F.
        • Ochoa J.B.
        • Faghiri Z.
        • et al.
        L-arginine regulates the expression of the T cell receptor zeta chain (CD3zeta) in Jurkat cells.
        Clin Cancer Res. 2001; 7: 958s-965s
        • Rodriguez P.C.
        • Ochoa A.C.
        Arginine regulation by myeloid derived suppressor cells and tolerance in cancer: mechanisms and therapeutic perspectives.
        Immunol Rev. 2008; 222: 180-191
        • Ochoa A.C.
        • Zea A.H.
        • Hernandez C.
        • et al.
        Arginase, prostaglandins, and myeloid-derived suppressor cells in renal cell carcinoma.
        Clin Cancer Res. 2007; 13: 721s-726s
        • Makarenkova V.P.
        • Bansal V.
        • Matta B.M.
        • et al.
        CD11b+/Gr-1+ myeloid suppressor cells cause T cell dysfunction after traumatic stress.
        J Immunol. 2006; 176: 2085-2094
        • Gabrilovich D.I.
        • Bronte V.
        • Chen S.H.
        • et al.
        The terminology issue for myeloid-derived suppressor cells.
        Cancer Res. 2007; 67: 425
        • Gabrilovich D.I.
        • Nagaraj S.
        Myeloid-derived suppressor cells as regulators of the immune system.
        Nat Rev Immunol. 2009; 9: 162-174
        • Bronte V.
        • Serafini P.
        • Apolloni E.
        • et al.
        Tumor-induced immune dysfunctions caused by myeloid suppressor cells.
        J Immunother. 2001; 24: 431-446
        • Barksdale A.R.
        • Bernard A.C.
        • Maley M.E.
        • et al.
        Regulation of arginase expression by T helper II cytokines and isoproterenol.
        Surgery. 2004; 135: 527-535
        • Bernard A.C.
        • Fitzpatrick E.A.
        • Maley M.E.
        • et al.
        Beta adrenoceptor regulation of macrophage arginase activity.
        Surgery. 2000; 127: 412-418
        • Rodriguez P.C.
        • Hernandez C.P.
        • Quiceno D.
        • et al.
        Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma.
        J Exp Med. 2005; 202: 931-939
        • Bansal V.
        • Ochoa J.B.
        Arginine availability, arginase, and the immune response.
        Curr Opin Clin Nutr Metab Care. 2003; 6: 223-228
        • Bansal V.
        • Syres K.M.
        • Makarenkova V.
        • et al.
        Interactions between fatty acids and arginine metabolism: implications for the design of immune-enhancing diets.
        JPEN J Parenter Enteral Nutr. 2005; 29: S75-S80
        • Okamoto Y.
        • Okano K.
        • Izuishi K.
        • et al.
        Attenuation of the systemic inflammatory response and infectious complications after gastrectomy with preoperative oral arginine and omega-3 fatty acids supplemented immunonutrition.
        World J Surg. 2009; 33: 1815-1821
        • Mirza N.
        • Fishman M.
        • Fricke I.
        • et al.
        All-trans-retinoic acid improves differentiation of myeloid cells and immune response in cancer patients.
        Cancer Res. 2006; 66: 9299-9307
        • Ochoa J.B.
        • Makarenkova V.
        • Bansal V.
        A rational us of immune enhancing diets: when should we use dietary arginine supplementation?.
        Nutr Clin Pract. 2004; 19: 216-225
        • Ochoa J.B.
        Separating pharmaconutrition from classic nutrition goals: a necessary step.
        Crit Care Med. 2008; 36: 347-348
        • Braga M.
        • Gianotti L.
        • Radaelli G.
        • et al.
        Perioperative immunonutrition in patients undergoing cancer surgery: results of a randomized double-blind phase 3 trial.
        Arch Surg. 1999; 134: 428-433
        • Braga M.
        • Gianotti L.
        • Vignali A.
        • et al.
        Preoperative oral arginine and n-3 fatty acid supplementation improves the immunometabolic host response and outcome after colorectal resection for cancer.
        Surgery. 2002; 132: 805-814
        • Kudsk K.A.
        • Minard G.
        • Croce M.A.
        • et al.
        A randomized trial of isonitrogenous enteral diets after severe trauma. An immune-enhancing diet reduces septic complications.
        Ann Surg. 1996; 224: 531-540